Loan & DebtApr 17, 2026, 05:22 PM
Revolution Medicines Issues $500M Convertible Senior Notes
AI Summary
Revolution Medicines, Inc. has issued $500 million aggregate principal amount of 0.50% Convertible Senior Notes due 2033. These notes are senior, unsecured obligations, with interest payable semi-annually beginning November 1, 2026. Noteholders will have conversion rights under specific conditions before February 1, 2033, and at their election thereafter until maturity.
Key Highlights
- Issued $500 million in Convertible Senior Notes.
- Notes carry a 0.50% annual interest rate.
- Maturity date is May 1, 2033.
- Interest paid semi-annually, starting Nov 1, 2026.